Human embryonic stem cell therapy used to treat spinal cord injuries will be studied for the first time. The United States Food and Drug Administration ruled to allow Geron, a U.S. biotechnology company, to begin testing human embryonic stem cell therapy on patients with recent spinal cord injuries.
It is great to see science coming back to life in the United States.
